1. Zhang, Jingjing, Li, Yun, Liu, Hua, Xu, Yingjie, Feng, Weiwei. 2022. Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis. In Journal of experimental & clinical cancer research : CR, 41, 24. doi:10.1186/s13046-022-02242-3. https://pubmed.ncbi.nlm.nih.gov/35033172/
2. Wang, Fang, Wang, Jianhua, Guo, Jin, Niu, Bo, Zhang, Ting. 2013. PCMT1 gene polymorphisms, maternal folate metabolism, and neural tube defects: a case-control study in a population with relatively low folate intake. In Genes & nutrition, 8, 581-7. doi:10.1007/s12263-013-0355-5. https://pubmed.ncbi.nlm.nih.gov/23918616/
3. Liu, Yiqi, Li, Haobing, Shen, Xiangyu, Zhong, Jing, Cao, Renxian. 2024. PCMT1 confirmed as a pan-cancer immune biomarker and a contributor to breast cancer metastasis. In American journal of cancer research, 14, 3711-3732. doi:10.62347/TYLL7952. https://pubmed.ncbi.nlm.nih.gov/39267673/
4. Liu, Jiahao, Liu, Baiying, Li, Yanan, Tan, Hongpei, Rong, Pengfei. 2023. PCMT1 is a potential target related to tumor progression and immune infiltration in liver cancer. In European journal of medical research, 28, 289. doi:10.1186/s40001-023-01216-1. https://pubmed.ncbi.nlm.nih.gov/37596654/
5. Shan, Liyun, Wang, Xiaoyun, Li, Yanli, Xi, Xiaowei, Yang, Yongbin. . Elevated expression of protein-L-isoaspartate O-methyltransferase-1 (PCMT1) in cervical cancer. In Translational cancer research, 11, 2582-2590. doi:10.21037/tcr-21-2700. https://pubmed.ncbi.nlm.nih.gov/36093534/
6. Zhao, Huizhi, Wang, Fang, Wang, Jianhua, Niu, Bo, Zhang, Ting. 2012. Maternal PCMT1 gene polymorphisms and the risk of neural tube defects in a Chinese population of Lvliang high-risk area. In Gene, 505, 340-4. doi:10.1016/j.gene.2012.05.035. https://pubmed.ncbi.nlm.nih.gov/22647835/
7. Dong, Liming, Li, Yanpei, Xue, Dongwei, Liu, Yili. 2018. PCMT1 is an unfavorable predictor and functions as an oncogene in bladder cancer. In IUBMB life, 70, 291-299. doi:10.1002/iub.1717. https://pubmed.ncbi.nlm.nih.gov/29517839/
智鼠故事 
